Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid
Clinical trial NCT02959918 · COMPLETED
Trial details
- NCT number
- NCT02959918
- Sponsor
- Selecta Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-12-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.